Breakthroughs & Innovations

Advancing Health Care with Cell Biology Research

diabetes concept hand holds blood glucose meter blood sugar level testing treatment monitoring diagnosis diabetes icon flat style isolated vector illustration 108855 3008

Diabetes

Diabetes affects over 537 million adults worldwide (as of 2021), and projections show this number could rise to 643 million by 2030 and 783 million by 2045.
Scientists have generated insulin-producing beta cells from stem cells and transplanted them into patients some now living without insulin. Stem cell therapies are rapidly emerging as a transformative frontier, with the global market projected to grow from $2.68 billion in 2024 to $14.6 billion by 2034.
scd imageryv2 03 0

Sickle Cell Disease:

Sickle cell disease (SCD) affects about 300,000 newborns annually worldwide, with over 20 million people living with the condition. For decades, bone marrow transplant was the only curative option.
FDA-approved cell-based gene therapies use CRISPR-Cas9 to edit a patient’s own blood stem cells, enabling the production of healthy fetal hemoglobin. In clinical trials, about 93.5% of patients remained free from sickle cell crises for at least a year after treatment.
cancer

Cancer

By 2040, new cancer cases are expected to rise to 28.4 million annually, driven by aging populations and lifestyle factors.
Stem cell and advanced immunotherapies are reshaping treatment, with engineered NK cells, cord blood stem cell transplants, dendritic cell vaccines, and mesenchymal stem cell-based delivery systems showing promising results in clinical trials.
hiv

HIV

HIV affects about 39 million people globally, and while antiretroviral therapy (ART) has made it manageable, cures remain rare.
To date, at least five individuals have been cured following hematopoietic stem cell transplants from donors with the CCR5-Δ32 mutation, including the New York Patient, the first woman cured using umbilical cord blood stem cells proving that HIV cure is biologically possible.
Scroll to Top